Published 2020
| Version v1
Publication
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic
Description
Randomized controlled trials (RCTs) are the best way to find effective and acceptable safe treatments for COVID-19 and any possible future outbreak. However, caution is needed when comparing the number of participants in RCTs with that of patients with COVID-19 treated with compassionate and/or off-label drugs to support the hypothesis that the latter are preferred by clinicians as an alternative to the former.
Additional details
- URL
- http://hdl.handle.net/11567/1016068
- URN
- urn:oai:iris.unige.it:11567/1016068
- Origin repository
- UNIGE